HighTower Advisors
RGEN icon

HighTower Advisors’s Repligen RGEN Stock Holding History

HighTower Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-800
Closed -$26.4K – 3910
2025
Q3 		$26.4K Buy
+800
New +$97.2K ﹤0.01% 3651

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

HighTower Advisors's RGEN Position: Q1 2026 in Review

HighTower Advisors reduced its Repligen (RGEN) stake by 49% in Q1 2026, selling an estimated $234K and leaving 1,759 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

HighTower Advisors first reported a position in RGEN in Q3 2017 and has held it in 35 quarters since. The position peaked at $5.15M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • HighTower Advisors held 1,759 shares of Repligen worth $207K as of Q1 2026.
  • HighTower Advisors sold 1,677 Repligen shares in Q1 2026, an estimated $234K.
  • Repligen made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3451 holding.
  • HighTower Advisors first reported a position in Repligen in Q3 2017 and has held it in 35 quarters since.
  • HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.